Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-08

Clinical Trial Update: Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost [Phase 4]

View source ↗

Summary

Phase 4 trial comparing two trabecular micro-bypass stents (iStent Inject) to travoprost in adults with open-angle glaucoma and related ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Travoprost (Travoprost (isomer-free))
  • iStent Inject

Snippet

Sponsor: Glaukos Corporation | Conditions: Open-angle Glaucoma | Phase 4 | Status: COMPLETED